Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03749434 · ClinicalTrials.gov registry record
Understanding and Addressing Variations in HAIs After Durable Ventricular Assist Device Therapy
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 34,958
- Enrollment target
NCT03749434 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 34,958 participants.
The verdict
NCT03749434 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 34,958 participants
- Enrollment target
Study Summary
Substantial center variability exists in healthcare-associated infection (HAI) rates following durable ventricular assist device (VAD) implantation for patients with advanced heart failure. Preliminary evidence suggests that this variability may be related to process (e.g., pre-operative intranasal mupirocin), provider (e.g., surgeon technique, physician teamwork), device, (e.g., centrifugal vs. axial flow), and center specific (e.g., infection prevention strategies and resources) factors. The investigators will undertake a mixed methods study to: (1) identify determinants of center-level variability in HAI rates, (2) develop a comprehensive understanding of barriers and facilitators for achieving low center HAI rates, and (3) develop, iteratively enhance, and disseminate a best practices toolkit for preventing HAIs that accommodates various center contexts.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34,958 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03749434
The ClinicalTrials.gov registry entry for NCT03749434 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34,958 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03749434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03749434 about?
NCT03749434 is a clinical study titled "Understanding and Addressing Variations in HAIs After Durable Ventricular Assist Device Therapy". Substantial center variability exists in healthcare-associated infection (HAI) rates following durable ventricular assist device (VAD) implantation for patients with advanced heart failure. Preliminary evidence suggests that this variability may be related to process (e.g., pre-operative intranasal ...
What is the current status of trial NCT03749434?
This trial is currently completed. The enrollment target is 34,958 participants. The study started on 2019-02-04. Estimated completion is 2024-06-30.
Who is sponsoring clinical trial NCT03749434?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.